Diagnosing MS typically involves multiple tests to rule out other conditions, as there is no single definitive test for MS. Magnetic resonance imaging (MRI) is the primary diagnostic tool for MS ...

Relapsing-remitting MS (RRMS) RRMS is the most common type of the disease. According to the National Multiple Sclerosis Society, about 85% of people with MS have RRMS at the time of diagnosis.

Many people with multiple sclerosis (MS) may wonder whether trying a certain diet — or eliminating a certain food group from their diet — can ward off MS symptoms, like fatigue or cognitive ...

Patients with relapsing-remitting multiple sclerosis (RRMS) in England, Wales and Northern Ireland can now access treatment with Biogen's oral therapy Vumerity, after NICE recommended the drug for ...

Learn more about the JH Preferred Income (HPI: XNYS) fund quote with Morningstar rating and analysis including NAV, star rating, asset allocation, capital gains, and dividends to help you stay up ...

The FDA has approved GlaxoSmithKline’s multiple myeloma drug Blenrep, a first-in-class potential blockbuster that will be used in advanced disease. Blenrep (belantamab mafodotin) has been ...